MedTrace Logo

The Nitrite and Coronary Flow Study

NCT04354051 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2020-04-21

No results posted yet for this study

Summary

This study is a pharmacodynamic proof of concept study investigating the physiological effects of systemic infusion of nitrite on coronary blood flow using MRI.

Conditions

Interventions

DRUG

Sodium Nitrite

Intravenous nitrite sodium infusion, dose 70μmol, of 5 minute duration (14μmol /min-1).

Sponsors & Collaborators

  • Royal Brompton & Harefield NHS Foundation Trust

    collaborator OTHER

  • University of East Anglia

    lead OTHER

Principal Investigators

  • Michael P Frenneaux, FRCP (UK) · University of East Anglia

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2018-12-01
Completion
2018-12-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04354051 on ClinicalTrials.gov